14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.81 $15.34 Friday, 17th May 2024 TRDA stock ended at $14.99. This is 0.268% more than the trading day before Thursday, 16th May 2024. During the day the stock fluctuated 3.79% from a day low at $14.78 to a day high of $15.34.
90 days $11.35 $15.34
52 weeks $10.83 $18.44

Historical Entrada Therapeutics, Inc. prices

Date Open High Low Close Volume
Nov 19, 2021 $33.71 $34.81 $32.58 $32.79 123 487
Nov 18, 2021 $35.00 $36.85 $33.30 $33.83 277 158
Nov 17, 2021 $34.50 $36.05 $33.00 $35.00 252 634
Nov 16, 2021 $34.21 $36.22 $32.41 $34.20 369 073
Nov 15, 2021 $32.85 $36.22 $32.58 $34.44 321 741
Nov 12, 2021 $31.30 $36.22 $31.30 $32.40 219 162
Nov 11, 2021 $29.49 $33.90 $29.27 $32.54 165 620
Nov 10, 2021 $29.08 $34.76 $28.16 $29.05 126 849
Nov 09, 2021 $24.83 $29.48 $24.83 $29.06 236 200
Nov 08, 2021 $23.32 $27.03 $22.80 $26.70 129 771
Nov 05, 2021 $25.33 $26.40 $21.39 $24.75 150 562
Nov 04, 2021 $24.29 $27.80 $24.00 $24.88 236 382
Nov 03, 2021 $23.97 $27.48 $23.40 $24.97 251 055
Nov 02, 2021 $21.99 $26.88 $21.99 $25.48 440 974
Nov 01, 2021 $24.79 $25.78 $20.00 $22.51 406 399
Oct 29, 2021 $26.50 $28.89 $22.20 $23.95 1 069 232

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use TRDA stock historical prices to predict future price movements?
Trend Analysis: Examine the TRDA stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the TRDA stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Entrada Therapeutics, Inc.

Entrada Therapeutics. Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also eng... TRDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT